4//SEC Filing
Wagner Klaus W. 4
Accession 0001739614-21-000020
CIK 0001739614other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 4:14 PM ET
Size
5.4 KB
Accession
0001739614-21-000020
Insider Transaction Report
Form 4
Inhibrx, Inc.INBX
Wagner Klaus W.
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-01-15+120,000→ 120,000 totalExercise: $33.63Exp: 2031-01-15→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1](1) Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on January 15, 2022, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
Documents
Issuer
Inhibrx, Inc.
CIK 0001739614
Entity typeother
Related Parties
1- filerCIK 0001766477
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 4:14 PM ET
- Size
- 5.4 KB